An Introduction to Other Agencies and Considerations Involved in Medical Product Advertising and Promotion

A session from FDLI’s Introduction to Advertising and Promotion for Medical Products
Recorded October 16, 2024

An Introduction to Other Agencies and Considerations Involved in Medical Product Advertising and Promotion

Cover the other agencies and entities that govern and impact advertising and promotion of medical products.

  • Federal Trade Commission (FTC) Authority
  • National Advertising Division (NAD)
  • Interactions with SEC
  • Lanham Act
  • False Claims Act, Qui tam Actions, and Anti-Kickback Statute
  • State Actions and Consumer Class Actions
  • PhRMA Code on Interactions with Healthcare Professionals
  • AdvaMed Code of Ethics
  • Sunshine Act

August Horvath, Partner, Foley Hoag LLP

This session was recorded as part of FDLI’s Introduction to Advertising and Promotion for Medical Products Course in October 2024. 

Get Access

$149
  • +$100 for nonmembers

Virtual Learning FAQ

On-demand webinar content is sent via email as soon as we are able to process and verify your order. This usually occurs within 1 business day.

 

On-demand content can be played back on most devices.

 

CLE credit is not currently available for pre-recorded sessions.

Related Content